Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/126860
Title: | Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium |
Author: | Huang, Ruyi Wei, Yongyue Hung, Rayjean J. Liu, Geoffrey Su, Li Zhang, Ruyang Zong, Xuchen Zhang, Zuo-Feng Morgenstern, Hal Brüske, Irene Heinrich, Joachim Hong, Yun-Chul Kim, Jin Hee Coté, Michele L. Wenzlaff, Angela Schwartz, Ann G. Stucker, Isabelle McLaughlin, John R. Marcus, Michael W. Davies, Michael P. A. Liloglou, Triantafillos Field, John K. Matsuo, Keitaro Barnett, Matt Thornquist, Mark D. Goodman, Gary E. Wang, Yi Chen, Size Yang, Ping Duell, Eric J. Andrew, Angeline S. Lazarus, Philip Muscat, Joshua E. Woll, Penella Horsman, Janet Teare, M. Dawn Flugelman, Anath Rennert, Gad Zhang, Yan Brenner, Hermann Stegmaier, Christa van der Heijden, Erik H. F. M. Aben, Katja K. Kiemeney, Lambertus A. L. M. Barros Dios, Juan M. Pérez Ríos, Mónica Ruano Ravina, Alberto Caporaso, Neil E. Bertazzi, Pier Alberto Landi, Maria Teresa Dai, Juncheng Shen, Hongbing Fernandez Tardon, Guillermo Rodriguez Suarez, Marta Tardón, Adonina Christiani, David C. |
Keywords: | Malalties pulmonars obstructives cròniques Càncer de pulmó Chronic obstructive pulmonary diseases Lung cancer |
Issue Date: | Nov-2015 |
Publisher: | Elsevier |
Abstract: | Background: The high relapse and mortality rate of small-cell lung cancer (SCLC) fuels the need for epidemiologic study to aid in its prevention. Methods: We included 24 studies from the ILCCO collaboration. Random-effects panel logistic regression and cubic spline regression were used to estimate the effects of smoking behaviors on SCLC risk and explore their non-linearity. Further, we explored whether the risk of smoking on SCLC was mediated through COPD. Findings: Significant dose-response relationships of SCLC risk were observed for all quantitative smoking variables. Smoking pack-years were associated with a sharper increase of SCLC risk for pack-years ranged 0 to approximately 50. The former smokers with longer cessation showed a 43%(quit_for_5-9 years) to 89%(quit_for_>= 20 years) declined SCLC risk vs. subjects who had quit smoking <5 years. Compared with non-COPD subjects, smoking behaviors showed a significantly higher effect on SCLC risk among COPD subjects, and further, COPD patients showed a 1.86-fold higher risk of SCLC. Furthermore, smoking behaviors on SCLC risk were significantly mediated through COPD which accounted for 0.70% to 7.55% of total effects. Interpretation: This is the largest pooling study that provides improved understanding of smoking on SCLC, and further demonstrates a causal pathway through COPD that warrants further experimental study. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.ebiom.2015.09.031 |
It is part of: | Ebiomedicine, 2015, vol. 2, num. 11, p. 1677-1685 |
URI: | https://hdl.handle.net/2445/126860 |
Related resource: | https://doi.org/10.1016/j.ebiom.2015.09.031 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
HuangRY.pdf | 548.03 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License